secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001193125-26-212117
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix shareholders approve 8M share increase in incentive plan; director Starcher faces 36% withhold vote
--------------------------------------------------------------------------------

- Shareholders approved the Second Amended and Restated 2008 Incentive Compensation Plan, increasing authorized shares by 8,000,000.
- Director John M. Starcher, Jr. received 46,296,745 votes for (55%) and 25,909,618 against (36% of votes cast excluding broker non-votes).
- PricewaterhouseCoopers LLP ratified as auditor for 2026 with 75,519,473 for (97.6% of votes cast).
- Advisory vote on named executive officer compensation for 2025 approved with 70,257,832 for (97.3% of votes cast excluding broker non-votes).
- All other director nominees received over 98% support from votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000119312526212117/0001193125-26-212117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000119312526212117/md-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-212117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer